REPLIGEN CORP 4
4 · REPLIGEN CORP · Filed May 22, 2017
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
COOPER GLENN L MD
Director
Transactions
- Award
Common Stock
2017-05-18+1,206→ 38,300 total - Award
Stock Option (Right to Buy)
2017-05-18+2,434→ 2,434 totalExercise: $38.76From: 2018-05-18Exp: 2027-05-18→ Common Stock (2,434 underlying)
Footnotes (2)
- [F1]Dr. Cooper was awarded 1,206 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Award vests in full one year from grant date on May 18, 2018.